Ugandan First Lady calls for increased efforts to prevent mother-to-child HIV transmission

Uganda's first lady Janet Museveni recently called for increased efforts to prevent mother-to-child HIV transmission in the country, Uganda's New Vision reports.

MTC prevention efforts are a prerequisite in the fight against HIV/AIDS, Museveni said, adding that more than 90% of pregnant women have contact with a health care provider at least once during pregnancy.

Museveni's comments were read by Adolf Mwesige, minister of local government, at the launch of a MTC prevention program in Uganda's Bushenyi district. According to Mwesige, the project is supported by the U.S. and will provide services to more than 7,000 HIV-positive pregnant women. According to the New Vision, it is estimated that more than 110,000 HIV-positive children live in Uganda, and more than 90% of HIV-positive children contracted HIV vertically (Ahimbisibwe, New Vision, 4/2).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HIV trial points to semaglutide as a new anti-aging contender